search icon
Blue 3D-rendered molecules connected by bonds floating against a dark, blurred background, suitable for representing topics or discussions related to peptides.

Presenters:

Angela DeRosa, DO, MBA, CPE, Scott Brunner, CAE

You’ve heard the buzz about peptides; now get the latest peptide compounding updates straight from the experts.

Belmar Pharma Solutions presents a Special Edition of our Preferred Provider webinars: “Peptide Updates and Q&A.”

Presented by:

  • Angela DeRosa, DO, MBA, CPE, Medical Director of Belmar Pharma Solutions
  • Scott Brunner, CAE, Chief Executive Officer, Alliance for Pharmacy Compounding

In This Interactive Webinar, We Talk Peptides:

  • Up-to-the-minute information about compounding peptides
  • What FDA says (or doesn’t say)
  • Insights from Scott Brunner (inside the APC)
  • Answers to YOUR questions by the experts!

*The information in this webinar is accurate and up to date as of its original presentation on August 21, 2026. Any FDA announcements since then may override this webinar’s original content.

Watch on-demand today.

This webinar is intended for providers. If you are a provider and would like to watch the webinar, please fill out the form below.

Presenters

Woman with red hair smiling, dressed in a patterned blouse and necklace, standing indoors with framed artwork in the background.

Angela DeRosa, DO, MBA, CPE

Medical Director, Belmar Pharma Solutions

Angela DeRosa, DO, MBA, CPE (“Dr. HotFlash”), is an internationally recognized expert in women’s hormonal health with more than 30 years of experience as a physician, educator, author, and speaker. As Medical Director at Belmar Pharma Solutions and Founder, Chief Medical Officer, and CEO of The Hormonal Health Institute, Dr. DeRosa is dedicated to advancing awareness and education around menopause and hormone health. Drawing from both clinical expertise and personal experience, she is a passionate advocate for empowering women to navigate every stage of hormonal wellness with confidence and support.

Connect on Linkedin
A smiling bald man with glasses and a beard, dressed in a dark shirt, stands indoors with shelves in the background.

Scott Brunner, CAE

Chief Executive Officer, Alliance for Pharmacy Compounding

Scott Brunner, CAE, is Chief Executive Officer of the Alliance for Pharmacy Compounding (APC), the national trade association representing the pharmacy compounding profession. Under his leadership, APC advocates for patient access to compounded medications and supports pharmacists, technicians, prescribers, educators, researchers, and suppliers across both 503A and 503B settings. Scott is a recognized voice in the compounding industry, dedicated to advancing policy, education, and awareness surrounding the critical role of compounded therapies in patient care.

Connect on Linkedin